Go Pro
→ Buy this stock tomorrow (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$54.65
+0.2%		$54.50
$37.28
▼
$57.35
$4.50B-0.41.86 million shs15.31 million shs
Oklo Inc. stock logo
OKLO
Oklo
$43.42
+5.3%		$52.27
$36.61
▼
$193.84
$7.17B1.178.73 million shs8.71 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%0.00%0.00%0.00%+12.40%
Oklo Inc. stock logo
OKLO
Oklo
+5.16%+9.72%-17.20%-45.62%-43.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$54.65
+0.2%		$54.50
$37.28
▼
$57.35
$4.50B-0.41.86 million shs15.31 million shs
Oklo Inc. stock logo
OKLO
Oklo
$43.42
+5.3%		$52.27
$36.61
▼
$193.84
$7.17B1.178.73 million shs8.71 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%0.00%0.00%0.00%+12.40%
Oklo Inc. stock logo
OKLO
Oklo
+5.16%+9.72%-17.20%-45.62%-43.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
2.00
Hold$54.670.03% Upside
Oklo Inc. stock logo
OKLO
Oklo
2.52
Moderate Buy$88.00102.66% Upside

Current Analyst Ratings Breakdown

Latest AKRO and OKLO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2026
Oklo Inc. stock logo
OKLO
Oklo
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$82.00 ➝ $76.00
7/13/2026
Oklo Inc. stock logo
OKLO
Oklo
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold$55.00
6/25/2026
Oklo Inc. stock logo
OKLO
Oklo
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral
6/11/2026
Oklo Inc. stock logo
OKLO
Oklo
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$60.00 ➝ $55.00
5/26/2026
Oklo Inc. stock logo
OKLO
Oklo
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$110.00
5/22/2026
Oklo Inc. stock logo
OKLO
Oklo
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$80.00
5/22/2026
Oklo Inc. stock logo
OKLO
Oklo
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$80.00
5/19/2026
Oklo Inc. stock logo
OKLO
Oklo
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoveragePeer Perform
5/14/2026
Oklo Inc. stock logo
OKLO
Oklo
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$73.50 ➝ $76.00
5/13/2026
Oklo Inc. stock logo
OKLO
Oklo
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/A$10.75 per shareN/A
Oklo Inc. stock logo
OKLO
Oklo
N/AN/AN/AN/A$9.45 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$252.06M-$1.94N/AN/AN/AN/A-15.86%-14.78%N/A
Oklo Inc. stock logo
OKLO
Oklo
-$105.66M-$0.84N/AN/AN/AN/A-8.57%-8.30%8/7/2026 (Confirmed)

Latest AKRO and OKLO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
Oklo Inc. stock logo
OKLO
Oklo
-$0.1638N/AN/AN/A$0.09 millionN/A
5/12/2026Q1 2026
Oklo Inc. stock logo
OKLO
Oklo
-$0.20-$0.19+$0.01-$0.19N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/AN/A
Oklo Inc. stock logo
OKLO
Oklo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
15.84
15.83
Oklo Inc. stock logo
OKLO
Oklo
N/A
59.93
59.93

Institutional Ownership

CompanyInstitutional Ownership
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
Oklo Inc. stock logo
OKLO
Oklo
85.03%

Insider Ownership

CompanyInsider Ownership
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
7.07%
Oklo Inc. stock logo
OKLO
Oklo
12.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3082.32 million76.50 millionOptionable
Oklo Inc. stock logo
OKLO
Oklo
78173.99 million151.89 millionOptionable

Recent News About These Companies

Oklo reports earnings on Aug. 7. Here's what investors should be watching
August 4 at 12:59 AM  |  msn.comhttps://www.msn.com/en-us/money/topstocks/oklo-reports-earnings-on-aug-7-heres-what-investors-should-be-watching/ar-AA29oYHI
Oklo (NYSE:OKLO) Shares Up 5.3% - Still a Buy?
August 4 at 6:40 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oklo-nyseoklo-shares-up-53-still-a-buy-2026-08-04/
Is Oklo Stock a No-Brainer Buy at Less Than $50?
August 4 at 2:58 PM  |  fool.comhttps://www.fool.com/investing/2026/08/04/is-oklo-stock-a-no-brainer-buy-at-less-than-50/
Nuclear Stocks To Watch Today - August 4th
August 4 at 1:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nuclear-stocks-to-watch-today-august-4th-2026-08-04/
Promising Nuclear Stocks To Watch Now - August 1st
August 4 at 4:05 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30940670
Oklo (NYSE:OKLO) Stock Price Up 6.3% - Here's Why
August 3 at 5:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oklo-nyseoklo-stock-price-up-63-heres-why-2026-08-03/
OKLO Stock Price Forecast — What Technical Indicators Say Ahead of Q2 Earnings
August 3 at 10:10 AM  |  tipranks.comhttps://www.tipranks.com/news/oklo-stock-price-forecast-what-technical-indicators-say-ahead-of-q2-earnings?utm_source=marketbeat.com&utm_medium=referral
Oklo (OKLO) Stock Looks Above Fair Value Following DOE Reactor Approval
August 3 at 8:33 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/oklo-oklo-stock-looks-above-060817084.html
If Wall Street Is Wrong About AI, Would Oklo Still Be Worth Buying?
August 3 at 8:33 AM  |  fool.comhttps://www.fool.com/investing/2026/08/03/if-wall-street-wrong-about-ai-oklo-worth-buying/
Project Prometheus: AI Powers Nuclear Energy
August 3 at 7:59 AM  |  etftrends.comE
Oklo Secures DOE Startup Authorization for Texas Isotope Reactor
August 2 at 7:16 PM  |  finance.yahoo.comhttps://finance.yahoo.com/energy/articles/oklo-secures-doe-startup-authorization-174840647.html
Promising Nuclear Stocks To Add to Your Watchlist - August 2nd
August 2 at 2:00 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/promising-nuclear-stocks-to-add-to-your-watchlist-august-2nd-2026-08-02/
Bloom Energy vs. Oklo: Which Power Stock Is a Better Buy in 2026?
August 2 at 2:00 PM  |  fool.comhttps://www.fool.com/coverage/better-buy/2026/08/02/bloom-energy-vs-oklo-which-power-stock-is-a-better-buy-in-2026/
Optiver Holding B.V. Invests $2.41 Million in Oklo Inc. $OKLO
August 2 at 6:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-optiver-holding-bv-invests-241-million-in-oklo-inc-oklo-2026-08-02/
Best Nuclear Stocks To Keep An Eye On - July 31st
August 2 at 4:37 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30936995
Is TerraPower the Next Oklo? Inside Bill Gates' Nuclear Bet.
August 1, 2026  |  fool.comhttps://www.fool.com/investing/2026/08/01/is-terrapower-the-next-olo-inside-bill-gates/
Oklo (NYSE:OKLO) Trading Down 5.2% - What's Next?
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oklo-nyseoklo-trading-down-52-whats-next-2026-07-31/
Oklo Secures DOE Startup Authorization for Texas Isotope Reactor
July 31, 2026  |  etftrends.comE
OKLO vs. Bloom Energy: Only One Clean Energy Stock Is a Buy
July 31, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2965498/oklo-vs-bloom-energy-only-one-clean-energy-stock-is-a-buy?cid=cs-stocknewsapi-ft-analyst_blog|most_popular_stocks-2965498
Oklo (OKLO) to Announce Earnings on Friday
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931590
Oklo (OKLO) Projected to Post Earnings on Friday
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oklo-oklo-projected-to-post-earnings-on-friday-2026-07-31/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A semiconductor wafer with the SK hynix logo displayed inside a manufacturing fabrication facility.
SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
By Thomas Hughes | July 7, 2026
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
Illustration of a quantum computing chandelier with the IQM logo, surrounded by cryogenic quantum computer units in a lab.
IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave
By Nathan Reiff | July 10, 2026
Akero Therapeutics stock logo

Akero Therapeutics NASDAQ:AKRO

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Oklo stock logo

Oklo NYSE:OKLO

$43.42 +2.20 (+5.34%)
Closing price 08/4/2026 03:59 PM Eastern
Extended Trading
$43.32 -0.11 (-0.25%)
As of 08:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas